Contrast-enhanced ultrasound is a reliable and reproducible assessment of necrotic ablated volume after radiofrequency ablation for benign thyroid nodules: a retrospective study

Reference

• Kim JH, Baek JH, Lim HK, Guideline Committee for the Korean Society of Thyroid Radiology (KSThR) and Korean Society of Radiology, et al. 2017 Thyroid radiofrequency ablation guideline: Korean society of thyroid radiology. Korean J Radiol. 2018;19(4):632–655.
   PubMed Web of Science ®Google Scholar
• Papini E, Pacella CM, Solbiati LA, et al. Minimally-invasive treatments for benign thyroid nodules: a delphi-based consensus statement from the italian minimally-invasive treatments of the thyroid (MITT) group. Int J Hyperthermia. 2019;36(1):376–382.
   PubMed Web of Science ®Google Scholar
• Ha EJ, Baek JH, Che Y, et al. Radiofrequency ablation of benign thyroid nodules: recommendations from the Asian conference on tumor ablation task force. Ultrasonography. 2021;40(1):75–82.
   PubMed Web of Science ®Google Scholar
• Dietrich CF, Müller T, Bojunga J, et al. Statement and recommendations on interventional ultrasound as a thyroid diagnostic and treatment procedure. Ultrasound Med Biol. 2018;44(1):14–36.
   PubMed Web of Science ®Google Scholar
• Papini E, Monpeyssen H, Frasoldati A, et al. 2020 European thyroid association clinical practice guideline for the use of image-guided ablation in benign thyroid nodules. Eur Thyroid J. 2020;9(4):172–185.
   PubMed Web of Science ®Google Scholar
• Dobnig H, Zechmann W, Hermann M, et al. Radiofrequency ablation of thyroid nodules: "Good Clinical Practice Recommendations" for Austria: An interdisciplinary statement from the following professional associations: Austrian Thyroid Association (ÖSDG), Austrian Society for Nuclear Medicine and Molecular Imaging (OGNMB), Austrian Society for Endocrinology and Metabolism (ÖGES), Surgical Endocrinology Working Group (ACE) of the Austrian Surgical Society (OEGCH). Wien Med Wochenschr. 2020;170(1-2):6–14.
   PubMed Web of Science ®Google Scholar
• Deandrea M, Sung JY, Limone P, et al. Efficacy and safety of radiofrequency ablation versus observation for nonfunctioning benign thyroid nodules: a randomized controlled international collaborative trial. Thyroid. 2015;25(8):890–896.
   PubMed Web of Science ®Google Scholar
• Cesareo R, Pasqualini V, Simeoni C, et al. Prospective study of effectiveness of ultrasound-guided radiofrequency ablation versus control group in patients affected by benign thyroid nodules. J. Clin. Endocrinol. Metab. 2015;100(2):460–466.
   PubMed Web of Science ®Google Scholar
• Hamidi O, Callstrom MR, Lee RA, et al. Outcomes of radiofrequency ablation therapy for large benign thyroid nodules: a Mayo clinic case series. Mayo Clin. Proc. 2018;93(8):1018–1025.
   PubMed Web of Science ®Google Scholar
• Cheng Z, Che Y, Yu S, et al. US-Guided percutaneous radiofrequency versus microwave ablation for benign thyroid nodules: a prospective multicenter study. Sci Rep. 2017;7(1):9554.
   PubMed Web of Science ®Google Scholar
• Radzina M, Cantisani V, Rauda M, et al. Update on the role of ultrasound guided radiofrequency ablation for thyroid nodule treatment. Int J Surg. 2017;41 Suppl 1(Suppl 1):S82–s93.
   PubMed Web of Science ®Google Scholar
• Guang Y, He W, Luo Y, et al. Patient satisfaction of radiofrequency ablation for symptomatic benign solid thyroid nodules: our experience for 2-year follow up. BMC Cancer. 2019;19(1):147.
   PubMed Web of Science ®Google Scholar
• Rabuffi P, Spada A, Bosco D, et al. Treatment of thyroid nodules with radiofrequency: a 1-year follow-up experience. J Ultrasound. 2019;22(2):193–199.
   PubMed Web of Science ®Google Scholar
• Kotewall N, Lang BHH. High-intensity focused ultrasound ablation as a treatment for benign thyroid diseases: the present and future. Ultrasonography. 2019;38(2):135–142.
   PubMed Web of Science ®Google Scholar
• Bernardi S, Dobrinja C, Carere A, et al. Patient satisfaction after thyroid RFA versus surgery for benign thyroid nodules: a telephone survey. Int J Hyperthermia. 2018;35(1):150–158.
   PubMed Web of Science ®Google Scholar
• Lang BH, Woo YC, Wong CKH. High-Intensity focused ultrasound for treatment of symptomatic benign thyroid nodules: a prospective study. Radiology. 2017;284(3):897–906.
   PubMed Web of Science ®Google Scholar
• Trimboli P, Castellana M, Sconfienza LM, et al. Efficacy of thermal ablation in benign non-functioning solid thyroid nodule: a systematic review and meta-analysis. Endocrine. 2020;67(1):35–43.
   PubMed Web of Science ®Google Scholar
• Chung SR, Suh CH, Baek JH, et al. Safety of radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: a systematic review and Meta-analysis. Int J Hyperthermia. 2017;33(8):920–930.
   PubMed Web of Science ®Google Scholar
• Lim HK, Lee JH, Ha EJ, et al. Radiofrequency ablation of benign non-functioning thyroid nodules: 4-year follow-up results for 111 patients. Eur Radiol. 2013;23(4):1044–1049.
   PubMed Web of Science ®Google Scholar
• Sim JS, Baek JH, Lee J, et al. Radiofrequency ablation of benign thyroid nodules: depicting early sign of regrowth by calculating vital volume. Int J Hyperthermia. 2017;33(8):905–910.
   PubMed Web of Science ®Google Scholar
• Sim JS, Baek JH. Long-Term outcomes following thermal ablation of benign thyroid nodules as an alternative to surgery: the importance of controlling regrowth. Endocrinol Metab. 2019;34(2):117–123.
   Web of Science ®Google Scholar
• Yan L, Luo Y, Xie F, et al. Residual vital ratio: predicting regrowth after radiofrequency ablation for benign thyroid nodules. Int J Hyperthermia. 2020;37(1):1139–1148.
   PubMed Web of Science ®Google Scholar
• Yan L, Luo Y, Zhang M, et al. Vital volume increase versus clinical evaluation as the indication of additional radiofrequency ablation for benign thyroid nodule: a single center retrospective study. Int J Hyperthermia. 2020;37(1):777–785.
   PubMed Web of Science ®Google Scholar
• Sim JS, Baek JH, Cho W. Initial ablation ratio: quantitative value predicting the therapeutic success of thyroid radiofrequency ablation. Thyroid. 2018;28(11):1443–1449.
   PubMed Web of Science ®Google Scholar
• Bernardi S, Cavallaro M, Colombin G, et al. Initial ablation ratio predicts volume reduction and retreatment after 5 years from radiofrequency ablation of benign thyroid nodules. Front Endocrinol (Lausanne)). 2020;11:582550.
   PubMed Web of Science ®Google Scholar
• Kang ST, Yeh CK. Ultrasound microbubble contrast agents for diagnostic and therapeutic applications: current status and future design. Chang Gung Med J. 2012;35(2):125–139.
   PubMedGoogle Scholar
• Alvarez-Sánchez MV, Napoléon B. Contrast-enhanced harmonic endoscopic ultrasound imaging: basic principles, present situation and future perspectives. World J Gastroenterol. 2014;20(42):15549–15563.
   PubMed Web of Science ®Google Scholar
• Albrecht T, Blomley M, Bolondi L, EFSUMB Study Group, et al. Guidelines for the use of contrast agents in ultrasound. January 2004. Ultraschall Med. 2004;25(4):249–256.
   PubMed Web of Science ®Google Scholar
• Lekht I, Gulati M, Nayyar M, et al. Role of contrast-enhanced ultrasound (CEUS) in evaluation of thermal ablation zone. Abdom Radiol (NY)). 2016;41(8):1511–1521.
   PubMed Web of Science ®Google Scholar
• Claudon M, Dietrich CF, Choi BI, European Federation of Societies for Ultrasound, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver - update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol. 2013;39(2):187–210.
   PubMed Web of Science ®Google Scholar
• Sidhu PS, Cantisani V, Dietrich CF, et al. The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017 (short version). Ultraschall Med. 2018;39(2):154–180.
   PubMed Web of Science ®Google Scholar
• Ma JJ, Ding H, Xu BH, et al. Diagnostic performances of various gray-scale, color doppler, and contrast-enhanced ultrasonography findings in predicting malignant thyroid nodules. Thyroid. 2014;24(2):355–363.
   PubMed Web of Science ®Google Scholar
• Yan L, Luo Y, Xiao J, et al. Non-enhanced ultrasound is not a satisfactory modality for measuring necrotic ablated volume after radiofrequency ablation of benign thyroid nodules: a comparison with contrast-enhanced ultrasound. Eur Radiol. 2021;31(5):3226–3236.
   PubMed Web of Science ®Google Scholar
• Schiaffino S, Serpi F, Rossi D, et al. Reproducibility of ablated volume measurement is higher with Contrast-Enhanced ultrasound than with B-Mode ultrasound after benign thyroid nodule radiofrequency Ablation-A preliminary study. J Clin Med. 2020;9:1504.
   PubMed Web of Science ®Google Scholar
• Mauri G, Pacella CM, Papini E, et al. Image-Guided thyroid ablation: proposal for standardization of terminology and reporting criteria. Thyroid. 2019;29(5):611–618.
   PubMed Web of Science ®Google Scholar
• Frates MC, Benson CB, Charboneau JW, Society of Radiologists in Ultrasound, et al. Management of thyroid nodules detected at US: society of radiologists in ultrasound consensus conference statement. Radiology. 2005;237(3):794–800.
   PubMed Web of Science ®Google Scholar
• Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15(2):155–163.
   PubMed Web of Science ®Google Scholar
• Anvari A, Halpern EF, Samir AE. Essentials of statistical methods for assessing reliability and agreement in quantitative imaging. Acad Radiol. 2018;25(3):391–396.
   PubMed Web of Science ®Google Scholar
• Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999;8(2):135–160.
   PubMed Web of Science ®Google Scholar
• Chhapola V, Kanwal SK, Brar R. Reporting standards for Bland-Altman agreement analysis in laboratory research: a cross-sectional survey of current practice. Ann Clin Biochem. 2015;52(Pt 3):382–386.
   PubMed Web of Science ®Google Scholar
• Mantha S, Roizen MF, Fleisher LA, et al. Comparing methods of clinical measurement: reporting standards for Bland and Altman analysis. Anesth Analg. 2000;90(3):593–602.
   PubMed Web of Science ®Google Scholar
• Lee HJ, Yoon DY, Seo YL, et al. Intraobserver and interobserver variability in ultrasound measurements of thyroid nodules. J Ultrasound Med. 2018;37(1):173–178.
   PubMed Web of Science ®Google Scholar
• Choi YJ, Baek JH, Hong MJ, et al. Inter-Observer variation in ultrasound measurement of the volume and diameter of thyroid nodules. Korean J Radiol. 2015;16(3):560–565.
   PubMed Web of Science ®Google Scholar
• Brauer VFH, Eder P, Miehle K, et al. Interobserver variation for ultrasound determination of thyroid nodule volumes. Thyroid. 2005;15(10):1169–1175.
   PubMed Web of Science ®Google Scholar
• Russ G, Bonnema SJ, Erdogan MF, et al. European thyroid association guidelines for ultrasound malignancy risk stratification of thyroid nodules in adults: the EU-TIRADS. Eur Thyroid J. 2017;6(5):225–237.
   PubMed Web of Science ®Google Scholar
• Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133.
   PubMed Web of Science ®Google Scholar
• Yan L, Luo Y, Song Q, et al. Inter-observer reliability in ultrasound measurement of benign thyroid nodules in the follow-up of radiofrequency ablation: a retrospective study. Int J Hyperthermia. 2020;37(1):1336–1344.
   PubMed Web of Science ®Google Scholar
• Chong WK, Papadopoulou V, Dayton PA. Imaging with ultrasound contrast agents: current status and future. Abdom Radiol. 2018;43(4):762–772.
   PubMed Web of Science ®Google Scholar
• Liu W, Zhou P, Zhao Y, et al. Superb microvascular imaging compared with Contrast-Enhanced ultrasound for assessing laser ablation treatment of benign thyroid nodules. Biomed Res Int. 2018;2018:1–8.
   Web of Science ®Google Scholar